IMMUNITYBIO, INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value
IMMUNITYBIO, INC. (IBRX) had Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value of $37.36 million as of 2019-03-31, per its 10-Q filed 2019-05-08.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue · last filed 2019-05-08
- 2019-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $37.36M.
- 2018-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $32.01M.
- 2018-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $43.24M.
- 2018-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $67.70M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value |
|---|---|
| 2019-03-31 | $37.36M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $32.01M 10-Q · filed 2019-05-08 |
| 2018-09-30 | $43.24M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $67.70M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $85.88M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $78.81M 10-K · filed 2019-03-13 |
| 2017-09-30 | $110.26M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $135.06M 10-Q · filed 2017-08-07 |
| 2017-03-31 | $158.00M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $173.92M 10-K · filed 2018-03-12 |
| 2015-12-31 | $152.27M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |